Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

Inclusion Criteria: * Ability to understand and consent to participate in this clinical research, expressed by signing the Informed Consent Form (ICF) * Male participants age 25 or older and 60 age or younger * Participants who have an intact scalp in the area of product analysis * Participants with androgenetic alopecia (AGA) with AGA Norwood-Hamilton Scale \> II * Participants with at least 20% telogen effluvium of evaluated by Tricholab Exclusion Criteria: * Participants who have used immunosuppressants in the 3 months prior to signing the ICF * Participants with other causes of hair loss or scalp dermatoses * Participants who have received hair loss treatment in the last 6 months * Participants with uncontrolled medical conditions, kidney and liver disease * Participants with a history of hair transplantation, malignancy, hematologic disorders, thyroid dysfunction, malnutrition, and other dermatologic disorders that contribute to hair loss